Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
| Brand name | ATORVASTATIN CALCIUM |
| Generic name | ATORVASTATIN CALCIUM |
| Active ingredient(s) | ATORVASTATIN |
| Distributed by / for | Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA |
| NDC | 75834-257-01 |
| Full product label | Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01. |
| Recalling firm | Nivagen Pharmaceuticals Inc |
| Distribution | Nationwide within the U.S |
| Quantity | 2328 bottles |
| Recall initiated | 2024-09-24 |
| Report date | 2024-10-09 |
| Recall completed | — |
| Recall number | D-0001-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Sacramento CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗